caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1922016567

Mark GodselDPM

PodiatryChicago, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Mark Godsel's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Jennifer Suffern
Podiatry · Chicago, IL
47114
NPI 12957092284183
COOK COUNTY36100
Thomas Patrianakos
Ophthalmology · Chicago, IL
2838
Anupam Basu
Diagnostic Radiology · Evanston, IL
1722
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
71
Unique beneficiaries
—
Total services
98
Distinct HCPCS
2
Medicare payment
$5K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 836 Podiatry providers in IL — bottom quintile (cohort median 1,546).
PRESCRIBING · PART D · 2024
Total Rx claims
21
Beneficiaries
—
Total drug cost
$639
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Clotrimazole21 claims
QUALITY · MIPS · 2024
Final MIPS score
95.1
Quality
74.7
Cost
85.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.